Unknown

Dataset Information

0

An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes.


ABSTRACT: N-glycosylation of a mAb may have a major impact on its therapeutic merits. Here, we demonstrate that expression of a hybrid enzyme (called xylGalT), consisting of the N-terminal domain of Arabidopsis thaliana xylosyltransferase and the catalytic domain of human beta-1,4-galactosyltransferase I (GalT), in tobacco causes a sharp reduction of N-glycans with potentially immunogenic core-bound xylose (Xyl) and fucose (Fuc) residues as shown by Western blot and MALDI-TOF MS analysis. A radioallergosorbent test inhibition assay with proteins purified from leaves of WT and these transgenic tobacco plants using sera from allergic patients suggests a significant reduction of potential immunogenicity of xylGalT proteins. A mAb purified from leaves of plants expressing xylGalT displayed an N-glycan profile that featured high levels of galactose, undetectable xylose, and a trace of fucose. Hence, a transgenic plant expressing the hybrid GalT might yield more effective and safer monoclonals for therapeutic purposes than WT plants and even transgenic plants expressing the unchanged GalT.

SUBMITTER: Bakker H 

PROVIDER: S-EPMC1472489 | biostudies-literature | 2006 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes.

Bakker Hans H   Rouwendal Gerard J A GJ   Karnoup Anton S AS   Florack Dion E A DE   Stoopen Geert M GM   Helsper Johannes P F G JP   van Ree Ronald R   van Die Irma I   Bosch Dirk D  

Proceedings of the National Academy of Sciences of the United States of America 20060504 20


N-glycosylation of a mAb may have a major impact on its therapeutic merits. Here, we demonstrate that expression of a hybrid enzyme (called xylGalT), consisting of the N-terminal domain of Arabidopsis thaliana xylosyltransferase and the catalytic domain of human beta-1,4-galactosyltransferase I (GalT), in tobacco causes a sharp reduction of N-glycans with potentially immunogenic core-bound xylose (Xyl) and fucose (Fuc) residues as shown by Western blot and MALDI-TOF MS analysis. A radioallergoso  ...[more]

Similar Datasets

| S-EPMC4742961 | biostudies-literature
| S-EPMC2365515 | biostudies-literature
| S-EPMC18444 | biostudies-literature
| S-EPMC6629611 | biostudies-literature
| S-EPMC3173110 | biostudies-literature
| S-EPMC5636615 | biostudies-literature
| S-EPMC8446519 | biostudies-literature
| S-EPMC3208265 | biostudies-literature
| S-EPMC3814792 | biostudies-literature
| S-EPMC2974045 | biostudies-literature